VCAN and gastric adenocarcinoma: Previous studies concerning Versican immunohistochemical staining have revealed that stromal Versican expression was significantly greater in the patients with advanced disease.7 Our data detected statistically significant differences in Versican expression levels between gastric adenocarcinoma and ANT, as well as between gastric adenocarcinoma and IN.